Summary
Hepatocellular death is present in almost all types of human liver
disease and is used as a sensitive parameter for the detection of acute and
chronic liver disease of viral, toxic, metabolic, or autoimmune origin. Clinical
data and animal models suggest that hepatocyte death is the key trigger of liver
disease progression, manifested by the subsequent development of inflammation,
fibrosis, cirrhosis, and hepatocellular carcinoma. Modes of hepatocellular death
differ substantially between liver diseases. Different modes of cell death such
as apoptosis, necrosis, and necroptosis trigger specific cell death responses
and promote progression of liver disease through distinct mechanisms. In this
review, we first discuss molecular mechanisms by which different modes of cell
death, damage-associated molecular patterns, and specific cell death responses
contribute to the development of liver disease. We then review the clinical
relevance of cell death, focusing on biomarkers; the contribution of cell death
to drug-induced, viral, and fatty liver disease and liver cancer; and evidence
for cell death pathways as therapeutic targets.